The global digital biomanufacturing market, valued at $2.4 billion in 2025, is projected to reach $2.8 billion in 2026 and $12.0 billion by 2035, representing a CAGR of 17.6% during the forecast period 2026 to 2035. In terms of type of technology, the manufacturing execution systems segment holds the highest share (nearly 35%) of the market. With respect to deployment option, the on-premises segment is dominating the market with ~70% of the market share. Iin-house developers segment captures the...

The global filtration market, valued at USD 6.5 billion in 2025, is projected to reach USD 7.2 billion in 2026 and USD 15.0 billion by 2035, with a 8.5% CAGR during the forecast period 2026 to 2035. In last five years, over 50 biologics been approved by the FDA and close to 10,000 biologics are being evaluated across different stages of development. Notably, biopharmaceutical filtration systems are used to separate and purify these biological products, including proteins, antibodies and vaccines...

The global continuous bioprocessing market is valued at USD 477.8 million in 2025 and is estimated to be worth USD 886.1 million in 2035, growing at a CAGR of 6.4% during the forecast period. Given the growing incidences of chronic diseases across the globe, pharmaceutical companies are experiencing the burden of developing biopharmaceutical drugs to treat patients. The usage of continuous bioprocessing reduces manufacturing cost (by 60%), optimization of resins (by 70%) in chromatography column...

With accelerated approval from the USFDA, several industrial players are taking strategic initiatives for technological innovations that help to explore more applications autologous cell therapies beyond cancer and autoimmune diseases. For instance, in November 2024, Nature Cell (a Korean biotechnology company) announced the success of autologous adipose stem cells that are delivered into spinal cavity of patient to treat Parkinson’s disease. This therapy has been developed by Japan Angel Stem...

The automatic aseptic sampling market, valued at USD 157 million in 2025, is projected to reach USD 191 million in 2026 and USD 913 million by 2035, with a 19% CAGR during the forecast period 2026 to 2035. Automated aseptic sampling offers several advantages, including real-time monitoring, improved productivity by up to 80%, and reduced deviation by around 65%. Additionally, the system offers diverse applications for lab automation, including analyte monitoring, bioprocessing, fraction collecti...

The global allogeneic cell therapy market valued at USD 50.0 million in 2025, is projected to grow to USD 52.4 million in 2026 and USD 1,629.6 million by 2035, representing a CAGR of 46.5% during the forecast period 2026 to 2035. Over the past few years, a number of allogeneic cell therapies targeting a myriad of disorders, such as hematological malignancies and neurological disorders have received approval from various regulatory authorities, globally. In December 2022, the European Commission...

The global single-use consumables market, valued at USD 3.42 billion in 2024, is projected to reach USD 4.02 billion in 2025 and USD 15.19 billion by 2035, representing a CAGR of 14.2% during the forecast period. The global market is categorized across different types of materials, such as metals, plastics, glass, biodegradable materials and other materials. Currently, plastics segment holds the highest share (65%) of the market. Based on the end user, the global market is segmented into biophar...

The telerehabilitation systems market is estimated to grow from USD 608.21 million in 2024 to reach USD 710.52 million in 2025 and USD 2,542.13 million by 2035, representing a higher CAGR of 13.6% during the forecast period. The telerehabilitation systems market analysis also features the likely distribution of the current and forecasted opportunity within the nutraceutical testing services domain across various segments, such as type of product, type of therapy, type of service, application are...

The global medical drones market, valued at USD 708 million in 2025, is projected to reach USD 793 million in 2026 and USD 2,608 million by 2035, with a 14.1% CAGR during the forecast period 2026 to 2035. Drones are becoming indispensable in the healthcare industry, serving various functions, such as delivering drugs, medical kits, vaccines, organs and surgical equipment. The heightened interest in the medical drones market can be validated by the fact that, in the last four years, more than USD...

The global super generics market, valued at USD 90.9 billion in 2025, is projected to reach USD 98.8 billion in 2026 and USD 199.5 billion by 2035, with a 8.12% CAGR during the forecast period 2026 to 2035. In the pharmaceutical industry, super generic drugs represent improved versions of an original pharmaceutical drug that have lost their patent exclusivity. These modified pharmacological interventions are commonly referred to as complex generics / value added generics. These enhanced versi...

The next generation sequencing market size, valued at USD 8.6 billion in 2025, is projected to reach USD 9.8 billion in 2026 and USD 46.5 billion by 2035, with a 18.9% CAGR during the forecast period 2026 to 2035. The market research report presents an in-depth analysis of the various next-generation sequencing companies across different segments. Key Next-generation Sequencing Technology providers profiled in the report include Illumina, MGI Tech, Oxford Nanopore Technologies, Pacific Bioscienc...

The global drug screening market, valued at USD 8.53 billion in 2024, is projected to reach USD 10.2 billion in 2025 and USD 37.31 billion by 2035, representing a CAGR of 14.1% during the forecast period. One of the key objectives of the drug screening market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. According to the drug screening market analysis, presently the product segment holds more than 55% of the market sha...

The global single use assemblies market, valued at USD 13.61 billion in 2024, is projected to reach USD 16.61 billion in 2025 and USD 81.53 billion by 2035, representing a CAGR of 17.2% during the forecast period. One of the key objectives of the single use assemblies market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. Based on the type of product, the global market is segmented into bag assemblies (2D bag assemblies...

North America in vitro diagnostics market, valued at USD 42 billion in 2024, is estimated to reach USD 44 billion in 2025 and USD 75 billion by 2035, representing a CAGR of 5.5% during the forecast period.

The global novel spectrometry market, valued at USD 5.3 billion in 2025, is projected to reach USD 5.6 billion in 2026 and USD 12 billion by 2035, with a 8.7% CAGR during the forecast period 2026 to 2035. At present, around 160 novel spectrometry platforms have been developed by several key players in the global marketplace. Based on the types of spectrometers, mass spectrometers hold 92% of the novel spectrometry market share and are likely to be a dominating segment in the market. Nuclear Magn...

Europe in vitro diagnostics market, valued at USD 32 billion in 2024, is estimated to reach USD 34 billion in 2025 and USD 57 billion by 2035, representing a CAGR of 5.4% during the forecast period.

The global deep learning market, valued at USD 6.4 billion in 2025, is projected to reach USD 8.2 billion in 2026 and USD 34.5 billion by 2035, with a 17.3% CAGR during the forecast period 2026 to 2035. With regards to therapeutic area, the oncological disorders segment dominates the global market. In terms of geographical regions, North America captures the majority of the market share.

The bone cement delivery system market, valued at USD 383 million in 2025, is projected to reach USD 407 million in 2026 and USD 501 billion by 2030, with a 7.0% CAGR during the forecast period 2026 to 2030. According to a study conducted by the International Osteoporosis Foundation (IOF), more than 200 million individuals around the world suffer from osteoporosis. In fact, the annual socioeconomic burden associated with this condition is estimated to be around USD 19 billion and EUR 37 billion,...

Asia Pacific in vitro diagnostics market, valued at USD 18 billion in 2024, is estimated to reach USD 19 billion in 2025 and USD 33 billion by 2035, representing a CAGR of 5.6% during the forecast period. On the basis of types of products, the Asia Pacific IVD market is distributed into instruments, reagents, and others. In Asia Pacific, the rising concern of chronic diseases such as diabetes, cardiovascular diseases, and infectious diseases necessitates developing in vitro diagnostics tests. Th...

The healthcare biometrics market is estimated to grow from USD 9.47 billion in 2024 to reach USD 12.0 billion in 2025 and USD 75.81 billion by 2035, representing a higher CAGR of 20.2% during the forecast period. According to our healthcare biometrics report, presently the finger recognition segment holds the highest share (38%) of the market. Healthcare biometrics market forecast, currently single factor authentication holds the highest share (57%) of the market. Presently, the hardware segment...